Myostatin: Regulator of Muscle Wasting in Heart Failure and Treatment Target for Cardiac Cachexia

Circulation - United States
doi 10.1161/cir.0b013e3181d0ba8b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Predictive Value of Cardiac Cachexia in Chronic Heart Failure

Cardiovascular Therapy and Prevention (Russian Federation)
Cardiovascular MedicineCardiology
2016English

Targeting RAGE Prevents Muscle Wasting and Prolongs Survival in Cancer Cachexia

Journal of Cachexia, Sarcopenia and Muscle
OrthopedicsSports MedicinePhysiology
2020English

Eicosapentaenoic Acid and Oxypurinol in the Treatment of Muscle Wasting in a Mouse Model of Cancer Cachexia

PLoS ONE
Multidisciplinary
2012English

Pathogenesis of Muscle Wasting in Cancer Cachexia: Targeted Anabolic and Anticatabolic Therapies

Current Opinion in Clinical Nutrition and Metabolic Care
MedicineNutritionDietetics
2010English

Muscle Wasting and Sarcopenia in Heart Failure: A Brief Overview of the Current Literature

ESC heart failure
Cardiovascular MedicineCardiology
2018English

The Countermeasure for Cancer Cachexia Related Muscle Wasting Does Not Need to Be Muscle Hyperplasia

Acta Physiologica
Physiology
2019English

Harnessing Cardiac Energetics in the Treatment of Heart Failure

Indian Journal of Cardiovascular Disease in Women WINCARS
2016English

Valvular Heart Diseases (7). Result of Cardiac Operation for Valvular Heart Disease With Cardiac Cachexia.

Japanese Journal of Cardiovascular Surgery
1990English

Heart Rate as a Target of Treatment of Chronic Heart Failure

Journal of Cardiology
Cardiovascular MedicineCardiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy